British pharmaceuticals giant AstraZeneca on Monday revealed more positive results from a trial of a treatment for Covid-19 symptoms. The drug, made from a combination of two antibodies, achieved a "statistically significant reduction in severe Covid-19 or death" in non-hospitalised patients with mild-to-moderate symptoms, AstraZeneca said in a statement.from UK News Headlines, Latest UK News and Live Updates - Times of India https://ift.tt/2YAZLUD
No comments:
Post a Comment